BRNS
Barinthus Biotherapeutics plc.
0.00 (0.00%)0.74USD0成交股數30.2M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | 0.00-100% | – | – | 0.00 | 15.0M+4382% | 0.00-100% | 0.00 | 0.00 | 334K | 468K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 3.9M | 3.6M | 5.4M | 8.0M | 8.3M | 8.3M | 11.1M | 11.7M | 11.1M | 15.1M | 13.5M | 9.8M |
| 銷售管理費用 | 7.1M | 2.5M | 5.2M | 15.4M | 12.6M | 3.1M | 13.4M | 7.2M | 6.0M | 961K | 13.1M | 12.1M |
| 營業利益 | −11.0M-47% | −6.1M-74% | −15.1M+61% | −23.3M+28% | −20.6M+22% | −23.4M+45% | −9.4M-64% | −18.3M-15% | −16.9M | −16.1M | −26.3M | −21.5M |
| 營業利益率 | – | – | – | – | – | – | -62.7% | – | – | – | -7,885.3% | -4,590.6% |
| 稅後淨利 | −10.6M-46% | −5.5M-73% | −14.6M+80% | −21.1M+25% | −19.6M+27% | −20.5M+46% | −8.1M-66% | −16.9M-7% | −15.5M | −14.1M | −23.8M | −18.2M |
| 淨利率 | – | – | – | – | – | – | -54.2% | – | – | – | -7,126.3% | -3,884.6% |
| 稀釋 EPS | -0.26-47% | -0.14-73% | -0.36+71% | -0.52+21% | -0.49+22% | -0.51+38% | -0.21-66% | -0.43-10% | -0.40 | -0.37 | -0.62 | -0.48 |
| 稀釋股數 | 40.8M | 40.8M | 40.7M | 40.3M | 40.3M | 39.3M | 39.4M | 39.0M | 38.8M | 38.5M | 38.4M | 38.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 59.3M | 65.9M | 74.3M | 86.3M | 99.1M | 111M | 106M | 118M | 130M | 160M | 173M | 191M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | 172K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 81.9M | 92.1M | 109M | 130M | 142M | 160M | 189M | 187M | 199M | 230M | 246M | 262M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 24.8M | 25.7M | 24.6M | 27.1M | 26.4M | 30.2M | 29.2M | 30.0M | 27.5M | 34.4M | 28.7M | 28.2M |
| 股東權益 | 57.1M | 66.4M | 84.5M | 102M | 115M | 130M | 159M | 157M | 172M | 195M | 217M | 233M |
| 負債比 | 30.2% | 27.9% | 22.6% | 20.9% | 18.6% | 18.8% | 15.5% | 16.0% | 13.8% | 14.9% | 11.6% | 10.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.4M | – | – | −14.9M+26% | – | – | – | −11.8M | – | – | −3.2M |
| 資本支出 | – | 0.00 | – | – | 5K | – | – | – | 308K | – | – | 2.5M |
| 自由現金流 | – | −3.4M | – | – | −14.9M+23% | – | – | – | −12.1M | – | – | −5.7M |
| 折舊攤銷 | – | 856K | – | – | 2.0M | – | – | – | 1.4M | – | – | 1.2M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | -1,213.9% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | -100.0% | −66.4M | –% | -1.64 | −48.0M |
| FY2024 | 15.0M | +1766.5% | −61.1M | -408.0% | -1.55 | −29.8M |
| FY2023 | 802K | -98.2% | −73.3M | -9,145.5% | -1.91 | −56.3M |
| FY2022 | 44.7M | +16580.2% | 5.3M | 11.9% | 0.14 | −20.6M |
| FY2021 | 268K | -94.4% | −50.9M | -18,979.5% | -1.96 | −33.7M |
| FY2020 | 4.8M | – | −17.7M | -367.3% | -2.24 | −11.3M |